Dong-A Socio Holdings Co., Ltd.
000640.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$626.13B
Close$
$194647.14
106.9% upside
Current Fair Value
106.9% upsideUndervalued by 106.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $626.13 Billion |
|---|---|
| Enterprise Value | $1.13 Trillion |
| Dividend Yield | $1700.00 (1.83%) |
| Earnings per Share | $13718 |
| Beta | 0.08 |
| Outstanding Shares | 6,730,000 |
Return
| Return on Equity | 7.15% |
|---|---|
| Return on Assets | 3.86% |
| Return on Invested Capital | 7.21% |
Valuation & Multiples
| P/E Ratio | 7.43 |
|---|---|
| PEG | -33.03 |
| Price to Sales | 0.42 |
| Price to Book Ratio | 0.52 |
| Enterprise Value to Revenue | 0.74 |
| Enterprise Value to EBIT | 10.52 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.61 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$6464.00
Average shareholder expectationRevenue Estimate
$393.65 B
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$5463.00
Average shareholder expectationRevenue Estimate
$423.35 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dong-A Socio Holdings Co., Ltd.
82 employees
CEO: Min-Young Kim Dong-A Socio Holdings Co., Ltd., established in Seoul, South Korea in 1932, maintains a prominent role in the pharmaceutical industry both within South Korea and globally. Its diverse product range includes well-known items such as Bacch...